Stone Conroy
General
Cases70
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
BiotechChemical BiotechMech Eng, Manuf
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
---|---|---|
11/19/24 | CLERK'S QUALITY CONTROL MESSAGE - Case Closed in Error, Please Disregard (ld, ) (Entered: 11/19/2024) | |
10/14/24 | Exhibit to [1] Complaint,,, Civil Cover Sheet by Treace Medical Concepts, Inc.. (CONROY, REBEKAH) (Entered: 10/14/2024) | |
10/14/24 | Exhibit to [1] Complaint,,, Revised Exhibit 24 (AO 120 Form) by Treace Medical Concepts, Inc.. (CONROY, REBEKAH) (Entered: 10/14/2024) | |
10/14/24 | Corporate Disclosure Statement by Treace Medical Concepts, Inc.. (CONROY, REBEKAH) (Entered: 10/14/2024) | |
10/14/24 | Exhibit to [1] Complaint,,, Unredacted Complaint (Filed Under Seal) by Treace Medical Concepts, Inc.. (CONROY, REBEKAH)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 10/14/2024) | |
10/14/24 | COMPLAINT against All Defendants ( Filing and Admin fee $ 405 receipt number ANJDC-15734875) with JURY DEMAND, filed by Treace Medical Concepts, Inc.. (Attachments: # [1] Exhibit Ex. 1 to Compl., # [2] Exhibit Ex. 2 to Compl., # [3] Exhibit Ex. 3 to Compl., # [4] Exhibit Ex. 4 to Compl., # [5] Exhibit Ex. 5t o Compl., # [6] Exhibit Ex. 6 to Compl., # [7] Exhibit Ex. 7 to Compl., # [8] Exhibit Ex. 8 to Compl., # [9] Exhibit Ex. 9 to Compl., # [10] Exhibit Ex. 10 to Compl., # [11] Exhibit Ex. 11 to Compl., # [12] Exhibit Ex. 12 to Compl., # [13] Exhibit Ex. 13 to Compl., # [14] Exhibit Ex. 14 to Compl., # [15] Exhibit Ex. 15 to Compl., # [16] Exhibit Ex. 16 to Compl., # [17] Exhibit Ex. 17 to Compl., # [18] Exhibit Ex. 18 to Compl., # [19] Exhibit Ex. 19 to Compl., # [20] Exhibit Ex. 20 to Compl., # [21] Exhibit Ex. 21 to Compl., # [22] Exhibit Ex. 22 to Compl., # [23] Exhibit Ex. 23 to Compl., # [24] AO120 Report)(CONROY, REBEKAH) (Entered: 10/14/2024) | |
10/11/24 | ANSWER to Complaint Plaintiffs' Answer to Alkem's Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024) | |
10/11/24 | ANSWER to Complaint Plaintiffs' Answer to Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited's Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024) | |
10/11/24 | ANSWER to Complaint Plaintiffs' Answer to Hikma Pharmaceuticals USA Inc.'s Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024) | |
10/11/24 | ANSWER to Complaint Plaintiffs' Answer to Hetero USA Inc., Hetero Labs Limited Unit-V, and Hetero Labs Ltd.'s Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024) |